News Focus
News Focus
icon url

Skiluc

05/08/21 12:19 PM

#62496 RE: Boy2roudy #62495

8k Sale of License Acquired shares for $250,000 cash consideration
Item 8.01 Other Events.
On April 21, 2021 Regen Biopharma, Inc. (the “Company”) sold 10,000 common shares of Oncology Pharma, Inc. to an unaffiliated third party for cash consideration of $250,000.
https://www.sec.gov/Archives/edgar/data/0001589150/000160706221000093/rgbp042121form8k.htm
icon url

hunterj20

05/08/21 2:38 PM

#62516 RE: Boy2roudy #62495

DO you not read the 8-k's? They just hired a patent attorney to dig out all their old patents!!! They have a lot to fund. They'll be selling more ONPH shares as they go, not diluting our RGBP commons any more. They do not want to have to do an A/S raise. Not rn. Maybe after buyout news LMAO